Original Article|Articles in Press

Perioperative Outcomes During Double-Lung Transplantation and Retransplantation in Cystic Fibrosis Patients: A Monocentric Cohort Study

Published:February 22, 2023DOI:


      Life expectancy for lung-transplant patients, especially those with cystic fibrosis (CF), is leading increasingly to more retransplantations.


      Retrospective monocentric cohort study.


      Foch University Hospital, Suresnes, France.


      CF patients having had a primary double-lung transplantation (pLgTx) or a retransplantation (reLgTx) from 2012 to 2021.



      Measurements and Main Results

      The authors compared the main intraoperative and early postoperative features between pLgTx (n = 258) and reLgTx (n = 24). Demographic characteristics were similar. No patients with retransplantations had a preoperative bridge with extracorporeal membrane oxygenation (ECMO); however, 23 patients had it in the pLgTx group (p = 0.24). Patients with retransplants had longer second graft ischemic time (p = 0.02), larger intraoperative bleeding volume (p = 0.001) and blood transfusion (p = 0.009 for packed red blood cells), increased blood lactate concentrations (p = 0.002), and higher norepinephrine dose at end-surgery (p = 0.001). Extracorporeal membrane oxygenation was used during surgery in 94 patients in the pLgTx group and 12 patients in the reLgTx group (p = 0.39). Extracorporeal membrane oxygenation could not be weaned after surgery in 55 patients in the pLgTx group and 4 in the reLgTx group (p = 0.54). Despite worse preoperative renal function in the reLgTx group (p < 0.001), there was no difference concerning renal replacement therapy in the intensive care unit between groups (p = 0.08). There were no differences between groups concerning the main complications, including primary graft dysfunction. Although the difference was not statistically different (p = 0.17), mortality was 3 times higher in the reLgTx group.


      Intraoperative period of retransplantation was more convoluted but had a similar ECMO profile to primary transplantation. In addition, the early postoperative period was similar.

      Graphical abstract

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Martin C
        • Reynaud-Gaubert M
        • Hamidfar R
        • et al.
        Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.
        J Cyst Fibros. 2022; 21: 489-496
        • Glanville AR
        • Verleden GM
        • Todd JL
        • et al.
        Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome- a consensus report from the Pulmonary Council of the ISHLT.
        J Heart Lung Transplant. 2019; 38: 483-492
        • Verleden GM
        • Glanville AR
        • Lease ED
        • et al.
        Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT.
        J Heart Lung Transplant. 2019; 38: 493-503
        • Chambers DC
        • Cherikh WS
        • Harhay MO
        • et al.
        The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: Donor and recipient size match.
        J Heart Lung Transplant. 2019; 38: 1042-1055
        • Yeung JC
        • Machuca TN
        • Chaparro C
        • et al.
        Lung transplantation for cystic fibrosis.
        J Heart Lung Transplant. 2020; 39: 553-560
        • Chan EG
        • Hyzny EJ
        • Ryan JP
        • et al.
        Outcomes following lung re-transplantation in patients with cystic fibrosis.
        J Cyst Fibros. 2022; 21: 482-488
        • Hartwig M
        • van Berkel V
        • Bharat A
        • et al.
        The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: The use of mechanical circulatory support in lung transplantation.
        J Thorac Cardiovasc Surg. 2023; 165: 301-326
        • Biswas Roy S
        • Panchanathan R
        • Walia R
        • et al.
        Lung retransplantation for chronic rejection: A single-center experience.
        Ann Thorac Surg. 2018; 105: 221-227
        • von Elm E
        • Altman DG
        • Egger M
        • et al.
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies.
        Int J Surg. 2014; 12: 1495-1499
      1. Anesthesia Foch lung transplantation protocol. 2020; (Available at) (Accessed January 30)
        • Fessler J
        • Sage E
        • Roux A
        • et al.
        Is extracorporeal membrane oxygenation withdrawal a safe option after double-lung transplantation?.
        Ann Thorac Surg. 2020; 110: 1167-1174
        • Snell GI
        • Yusen RD
        • Weill D
        • et al.
        Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-a 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
        J Heart Lung Transplant. 2017; 36: 1097-1103
        • Ostermann M
        • Bellomo R
        • Burdmann EA
        • et al.
        Controversies in acute kidney injury: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
        Kidney Int. 2020; 98: 294-309
        • Fessler J
        • Fischler M
        • Sage E
        • et al.
        Operating room extubation: A predictive factor for 1-year survival after double-lung transplantation.
        J Heart Lung Transplant. 2021; 40: 334-342
        • Oto T
        • Levvey BJ
        • Whitford H
        • et al.
        Feasibility and utility of a lung donor score: Correlation with early post-transplant outcomes.
        Ann Thorac Surg. 2007; 83: 257-263
        • Kim CY
        • Kim SY
        • Song JH
        • et al.
        Usefulness of the preoperative prognostic nutritional index score as a predictor of the outcomes of lung transplantation: A single-institution experience.
        Clin Nutr. 2019; 38: 2423-2429
        • Sommer W
        • Ius F
        • Kuhn C
        • et al.
        Technique and outcomes of less invasive lung retransplantation.
        Transplantation. 2018; 102: 530-537
        • Furfaro D
        • Rosenzweig EB
        • Shah L
        • et al.
        Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.
        J Heart Lung Transplant. 2021; 40: 1641-1648
        • Inci I
        • Ehrsam JP
        • Van Raemdonck D
        • et al.
        Extracorporeal life support as a bridge to pulmonary retransplantation: Prognostic factors for survival in a multicentre cohort analysis.
        Eur J Cardiothorac Surg. 2022; 61: 405-412
        • Hayes Jr, D
        • Higgins RS
        • Kilic A
        • et al.
        Extracorporeal membrane oxygenation and retransplantation in lung transplantation: An analysis of the UNOS registry.
        Lung. 2014; 192: 571-576
        • Parquin F
        • Zuber B
        • Vallee A
        • et al.
        A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome.
        Eur Respir J. 2021; 582004090
        • Scaravilli V
        • Morlacchi LC
        • Merrino A
        • et al.
        Intraoperative extracorporeal membrane oxygenation for lung transplantation in cystic fibrosis patients: Predictors and impact on outcome.
        J Cyst Fibros. 2020; 19: 659-665
        • Hayanga JWA
        • Chan EG
        • Musgrove K
        • et al.
        Extracorporeal membrane oxygenation in the perioperative care of the lung transplant patient.
        Semin Cardiothorac Vasc Anesth. 2020; 24: 45-53
        • Hoetzenecker K
        • Benazzo A
        • Stork T
        • et al.
        Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: An observational study.
        J Thorac Cardiovasc Surg. 2020; 160 (e321): 320-327
        • Calabrese F
        • Pezzuto F
        • Fortarezza F
        • et al.
        Evaluation of tissue ischemia/reperfusion injury in lung recipients supported by intraoperative extracorporeal membrane oxygenation: A single-center pilot study.
        Cells. 2022; 11: 3681
        • Durila M
        • Vajter J
        • Garaj M
        • et al.
        Rotational thromboelastometry reduces blood loss and blood product usage after lung transplantation.
        J Heart Lung Transplant. 2021; 40: 631-641
        • Fessler J
        • Vallee A
        • Guirimand A
        • et al.
        Blood lactate during double-lung transplantation: A predictor of grade-3 primary graft dysfunction.
        J Cardiothorac Vasc Anesth. 2022; 36: 794-804
        • Ren D
        • Kaleekal TS
        • Graviss EA
        • et al.
        Retransplantation outcomes at a large lung transplantation program.
        Transplant Direct. 2018; 4: e404
        • Halloran K
        • Aversa M
        • Tinckam K
        • et al.
        Comprehensive outcomes after lung retransplantation: A single-center review.
        Clin Transplant. 2018; 32: e13281